FDA Approves First Generic Single-Dose Flu Treatment

The US Food and Drug Administration (FDA) has approved the first generic single-dose treatment for influenza. This represents a significant step in making antiviral flu treatment more accessible to patients. Generic medications are more affordable alternatives to brand-name drugs while containing the same active ingredients. The single-dose format simplifies treatment and improves patient compliance with prescribed therapy. This approval expands flu treatment options and increases accessibility for a broader population.